Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12463
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCheah, A L Y-
dc.contributor.authorSpelman, T-
dc.contributor.authorPeel, T-
dc.contributor.authorHowden, Benjamin P-
dc.contributor.authorSpelman, D-
dc.contributor.authorGrayson, M Lindsay-
dc.contributor.authorNation, R L-
dc.contributor.authorKong, D C M-
dc.date.accessioned2015-05-16T02:09:52Z
dc.date.available2015-05-16T02:09:52Z
dc.date.issued2014-12-01-
dc.identifier.citationEpidemiology and Infection; 142(12): 2667-71en_US
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12463en
dc.description.abstractThe impact of vanB vancomycin-resistant enterococci (VRE) bacteraemia on length of stay (LOS) in hospital, after adjusting for the time-varying nature of enterococcal bacteraemia (variable onset of bacteraemia post-admission), is unknown. Survival analyses (time-varying Cox and competing risks regression) were performed on vanB VRE bacteraemia patients, matched 1:1 with vancomycin-susceptible enterococci bacteraemia patients to determine the factors associated with LOS in these patients. In Cox regression analysis, vanB VRE bacteraemia, intensive-care-unit admission, Charlson co-morbidity index score ⩾4, and an increase in the time to receive appropriate antibiotics were associated with prolonged LOS. Competing risks regression which accounts for the influence of in-patient mortality on the ability to observe the event discharge alive from hospital suggests that, vanB VRE bacteraemia was not significantly associated with prolonged LOS. For the first time, the rate of discharge from hospital in patients with vanB VRE bacteraemia has been quantified.en_US
dc.language.isoenen
dc.subject.otherAnti-Bacterial Agents.therapeutic useen
dc.subject.otherBacteremia.drug therapy.microbiology.mortalityen
dc.subject.otherCross Infection.drug therapy.microbiology.mortalityen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherLength of Stay.statistics & numerical dataen
dc.subject.otherMaleen
dc.subject.otherSurvival Analysisen
dc.subject.otherVancomycin Resistanceen
dc.subject.otherVancomycin-Resistant Enterococci.drug effects.isolation & purificationen
dc.titleImpact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEpidemiology and Infectionen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationCentre for Population Health,Burnet Institute,Prahran, Victoria,Australiaen_US
dc.identifier.affiliationCentre for Medicine Use and Safety,Monash University,Parkville, Victoria,Australiaen_US
dc.identifier.affiliationDepartment of Infectious Diseases, The Alfred, Melbourne, Victoria,Australiaen_US
dc.identifier.affiliationDepartment of Surgery, St Vincent's Health,University of Melbourne,Melbourne,Australiaen_US
dc.identifier.doi10.1017/S095026881400020Xen_US
dc.description.pages2667-71en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25372228en
dc.type.contentTexten_US
dc.type.austinJournal Articleen
local.name.researcherGrayson, M Lindsay
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMicrobiology-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Dec 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.